Literature DB >> 11434213

Biochemical and pharmacological investigations of selected cyanobacteria.

S Mundt1, S Kreitlow, A Nowotny, U Effmert.   

Abstract

Cyanobacteria are a very old group of prokaryotic organisms that produce a variety of secondary metabolites with antibiotic, algicide, cytotoxic, immunosuppressive and enzyme inhibiting activities. In the last decades structures of pure compounds have been determined as phenols, peptides, alkaloids or terpenoids (Falch, 1996). Screening of lipophilic and hydrophilic extracts from cultured cyanobacteria or waterbloom material, isolated from German lakes and the Baltic sea for antiviral, antibiotic, immunomodulating and enzyme inhibiting activity in different in vitro systems revealed strains with interesting effects. These strains were cultivated in 45 litre photobioreactors to produce enough biomass for bioassay-guided isolation of the active substances. First results characterising active substances are reported.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434213     DOI: 10.1078/1438-4639-00045

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  16 in total

1.  Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua.

Authors:  Shunyan Mo; Aleksej Krunic; George Chlipala; Jimmy Orjala
Journal:  J Nat Prod       Date:  2009-05-22       Impact factor: 4.050

Review 2.  Unraveling cyanobacteria ecology in wastewater treatment plants (WWTP).

Authors:  Joana Martins; Luísa Peixe; Vítor M Vasconcelos
Journal:  Microb Ecol       Date:  2011-02-02       Impact factor: 4.552

3.  Anti-MRSA-acting carbamidocyclophanes H-L from the Vietnamese cyanobacterium Nostoc sp. CAVN2.

Authors:  Michael Preisitsch; Kirsten Harmrolfs; Hang T L Pham; Stefan E Heiden; Anna Füssel; Christoph Wiesner; Alexander Pretsch; Monika Swiatecka-Hagenbruch; Timo H J Niedermeyer; Rolf Müller; Sabine Mundt
Journal:  J Antibiot (Tokyo)       Date:  2014-09-03       Impact factor: 2.649

4.  Primary screening of the bioactivity of brackishwater cyanobacteria: toxicity of crude extracts to Artemia salina larvae and Paracentrotus lividus embryos.

Authors:  Viviana R Lopes; Nuria Fernández; Rosário F Martins; Vitor Vasconcelos
Journal:  Mar Drugs       Date:  2010-03-05       Impact factor: 5.118

5.  In vitro antibacterial evaluation of Anabaena sp. against several clinically significant microflora and HPTLC analysis of its active crude extracts.

Authors:  Abhishek Chauhan; Garima Chauhan; Prakash C Gupta; Pankaj Goyal; P Kaushik
Journal:  Indian J Pharmacol       Date:  2010-04       Impact factor: 1.200

6.  Evaluation of phytotherapeutic activities and phytochemical content of Phormidium autumnale Gomont from natural freshwater sources.

Authors:  Dilek Yalcin; Hikmet Türk Katircioğlu; Tülay Özer; Minoo Pourhassan Shamchi; İlkay Acikgoz Erkaya
Journal:  Environ Monit Assess       Date:  2020-03-20       Impact factor: 2.513

7.  In vitro antibacterial activity of laboratory grown culture of Spirulina platensis.

Authors:  P Kaushik; Abhishek Chauhan
Journal:  Indian J Microbiol       Date:  2009-03-25       Impact factor: 2.461

8.  Bioactivity of benthic and picoplanktonic estuarine cyanobacteria on growth of photoautotrophs: inhibition versus stimulation.

Authors:  Viviana R Lopes; Vitor M Vasconcelos
Journal:  Mar Drugs       Date:  2011-05-10       Impact factor: 6.085

9.  Antimicrobial and cytotoxic assessment of marine cyanobacteria - Synechocystis and Synechococcus.

Authors:  R F Martins; M F Ramos; L Herfindal; J A Sousa; K Skaerven; V M Vasconcelos
Journal:  Mar Drugs       Date:  2008-01-22       Impact factor: 5.118

10.  Effects of Halide Ions on the Carbamidocyclophane Biosynthesis in Nostoc sp. CAVN2.

Authors:  Michael Preisitsch; Stefan E Heiden; Monika Beerbaum; Timo H J Niedermeyer; Marie Schneefeld; Jennifer Herrmann; Jana Kumpfmüller; Andrea Thürmer; Inga Neidhardt; Christoph Wiesner; Rolf Daniel; Rolf Müller; Franz-Christoph Bange; Peter Schmieder; Thomas Schweder; Sabine Mundt
Journal:  Mar Drugs       Date:  2016-01-20       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.